dysadherin FXYD5 ovarian cancer Short Report survival TCGA
Ovarian cancer (OC) is a leading cause of cancer mortality, but aside from a few well-studied mutations, very little is known about its underlying causes. As such, we performed survival analysis on ovarian copy number amplifications and gene expression datasets presented by The Cancer Genome Atlas in order to identify potential drivers and markers of aggressive OC. Additionally, two independent datasets from the Gene Expression Omnibus web platform were used to validate the identified markers. Based on our analysis, we identified
FXYD5
, a glycoprotein known to reduce cell adhesion, as a potential driver of metastasis and a significant predictor of mortality in OC. As a marker of poor outcome, the protein has effective antibodies against it for use in tissue arrays.
FXYD5
bridges together a wide variety of cancers, including ovarian, breast cancer stage II, thyroid, colorectal, pancreatic, and head and neck cancers for metastasis studies.
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
Creators
Pichai Raman - School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA, USA ; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, PA, USA ; Fara Diagnostics, Philadelphia, PA, USA.
Timothy Purwin - Drexel University
Richard Pestell - Thomas Jefferson University
Aydin Tozeren - Drexel University
Publication Details
Cancer informatics, v 14(2015), pp 113-119
Publisher
Libertas Academica
Resource Type
Journal article
Language
English
Academic Unit
[Retired Faculty]
Web of Science ID
WOS:000383958600002
Scopus ID
2-s2.0-84949951649
Other Identifier
991019168557904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: